NuCana (NCNA) Tax Provisions (2017 - 2025)
NuCana (NCNA) reported Tax Provisions of $188883.6 for Q4 2025, up 7.42% on a YoY basis from $175839.8 in Q4 2024, and down 59.43% sequentially from $465529.9 in Q3 2025.
NuCana (NCNA) Tax Provisions (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Tax Provisions data on file, last reported at $188883.6 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 7.42% year-over-year to $188883.6; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (down 65.06% YoY), and the FY2025 full-year result was $1.5 million, down 65.12% from the prior year.
- Tax Provisions retreated to $188883.6 in Q4 2025, from $465529.9 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.8 million in Q4 2021 to a low of $175839.8 in Q4 2024.
- A 5-year average of $1.5 million and a median of $1.6 million in 2023 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 87.3% in 2024, while the deepest fall reached 89.23% in 2024.
- Tracing NCNA's Tax Provisions over 5 years: stood at $2.8 million in 2021, then retreated by 26.05% to $2.1 million in 2022, then slipped by 20.94% to $1.6 million in 2023, then slumped by 89.23% to $175839.8 in 2024, then rose by 7.42% to $188883.6 in 2025.
- Business Quant data shows NCNA's Tax Provisions at $188883.6 in Q4 2025, $465529.9 in Q3 2025, and $437567.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | NuCana | 14.60 Bn | 14.60 Bn | - | 188,883.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 188,883.60 |
| Sep 30, 2025 | 465,529.94 |
| Jun 30, 2025 | 437,566.98 |
| Mar 31, 2025 | 444,603.69 |
| Dec 31, 2024 | 175,839.75 |
| Sep 30, 2024 | 961,482.12 |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 857,183.76 |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | 2.06 Mn |
| Sep 30, 2022 | 1.70 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 2.73 Mn |
| Dec 31, 2021 | 2.79 Mn |
| Sep 30, 2021 | 2.63 Mn |
| Jun 30, 2021 | 2.22 Mn |
| Mar 31, 2021 | 2.35 Mn |